Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Steroid Refractory Gastro-intestinal Acute Graft-versus-Host disEase afteR AllogeneiC Hematopoietic Stem celL Transplantation With fEcal Microbiota tranSfer

NCT03359980 is registered in ClinicalTrials.gov with MaaT Pharma as lead sponsor.

NCT NCT03359980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03359980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Steroid Refractory Gastro-intestinal Acute Graft-versus-Host disEase afteR AllogeneiC Hematopoietic Stem celL Transplantation With fEcal Microbiota tranSfer
Lead sponsor
MaaT Pharma
Phase
Phase 2
Overall status
Completed
Start date
August 13, 2018
Completion date
November 26, 2020
Enrollment
24 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

fecal microbiota transplantation